Literature DB >> 19022420

Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus.

A Tabarin1, S Bardet, J Bertherat, B Dupas, O Chabre, E Hamoir, F Laurent, F Tenenbaum, M Cazalda, H Lefebvre, N Valli, V Rohmer.   

Abstract

The French Society of Endocrinology convened a multidisciplinary panel of endocrinologists, radiologists, nuclear physicians and surgeons to address the appropriate evaluation and treatment of adrenal incidentalomas. The panel conducted a systematic review of medical literature on the following issues: epidemiology, natural history, radiological and scintigraphic evaluation, endocrine assessment, surgical management and appropriate follow-up. The following text reports the recommendations of experts on behalf of the French Society of Endocrinology. The authors emphasize the paucity of published scientific data that hampers evidence-based medicine recommendations. The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.

Entities:  

Mesh:

Year:  2008        PMID: 19022420     DOI: 10.1016/j.ando.2008.09.003

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  17 in total

Review 1.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?

Authors:  Serkan Yener; Hamiyet Yilmaz; Tevfik Demir; Mustafa Secil; Abdurrahman Comlekci
Journal:  Endocrine       Date:  2014-08-22       Impact factor: 3.633

3.  Six controversial issues on subclinical Cushing's syndrome.

Authors:  Iacopo Chiodini; Adriana Albani; Alberto Giacinto Ambrogio; Michela Campo; Maria Cristina De Martino; Giorgia Marcelli; Valentina Morelli; Benedetta Zampetti; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

Review 4.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

Review 5.  Glucose metabolism in patients with subclinical Cushing's syndrome.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Elisa Marinazzo; Andreea Picu; Ezio Ghigo; Emanuela Arvat
Journal:  Endocrine       Date:  2012-03-06       Impact factor: 3.633

6.  Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.

Authors:  M Vieira-Correa; R B Giorgi; K C Oliveira; L F Hayashi; F A Costa-Barbosa; C E Kater
Journal:  J Endocrinol Invest       Date:  2019-08-27       Impact factor: 4.256

7.  Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.

Authors:  G Reimondo; B Allasino; S Bovio; L Saba; A Ardito; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

8.  Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing's syndrome.

Authors:  Roberta Giordano; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Andreea Picu; Clizia Zichi; Beatrice Fussotto; Maria Manzo; Giulio Mengozzi; Ezio Ghigo; Emanuela Arvat
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

9.  A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion.

Authors:  Camilla Schalin-Jäntti; Merja Raade; Esa Hämäläinen; Timo Sane
Journal:  Endocrinol Metab (Seoul)       Date:  2015-09-10

Review 10.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.